GPT and metabolic dysfunction-associated steatotic liver disease: The increased levels of the liver enzymes including ALT, aspartate aminotransferase (AST), and γ-glutamyl transferase (GGT) are the markers of NAFLD and the occurrence of CVD events in both nondiabetic subjects and the patients with type 2 diabetes [8].